All Stories

  1. Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  2. Weltweite Perspektiven von Krankenhauspatienten zum Einsatz von künstlicher Intelligenz im Gesundheitswesen: Ergebnisse der COMFORT-Studie aus 74 Krankenhäusern in 43 Ländern
  3. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  4. Global cross-sectional student survey on AI in medical, dental, and veterinary education and practice at 192 faculties
  5. Assessment of comorbidities in COPD patients by chest HRCT
  6. Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  7. Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity
  8. Particularities of comorbidities in nonalcoholic fatty liver disease according to gender groups
  9. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  10. Editorial: Treatment of comorbidities of asthma and its safety
  11. Inhaledversussystemic corticosteroids for acute exacerbations of COPD: a systematic review and meta-analysis
  12. Hypersensitivity Pneumonitis: Challenges of a Complex Disease
  13. Medical students’ perceptions towards artificial intelligence in education and practice: A multinational, multicenter cross-sectional study
  14. Israel−Palestine Conflict: Risk of Sleep Disorders and Post-Traumatic Stress Disorders
  15. Promising treatment biomarkers in asthma
  16. Complications of tracheobronchial foreign body aspiration in children
  17. The Burden of Comorbidities in Obstructive Sleep Apnea
  18. Combined Pulmonary Fibrosis and Emphysema: Comparative Evidence on a Complex Condition
  19. Prevalence and Burden of Comorbidities in Obstructive Sleep Apnea Syndrome
  20. Characterisation of the Antibody Response in Sinopharm (BBIBP-CorV) Recipients and COVID-19 Convalescent Sera from the Republic of Moldova
  21. Updates in screening for tuberculosis. Review of guidelines
  22. Diagnostic challenges of a rare disease with an unusual presentation
  23. Peripheral neuropathy: A neglected cause of disability in COPD – A narrative review
  24. Predictors of the Efficacy for Daytime Sleepiness in Patients With Obstructive Sleep Apnea With Continual Positive Airway Pressure Therapy: A Meta-Analysis of Randomized Controlled Trials
  25. COPD and Diabetes Mellitus: Down the Rabbit Hole
  26. Scientists Against War: A Plea to World Leaders for Better Governance
  27. COPD and comorbidities in the Republic of Moldova
  28. Management of COVID-19-Associated Acute Respiratory Failure with Alternatives to Invasive Mechanical Ventilation: High-Flow Oxygen, Continuous Positive Airway Pressure, and Noninvasive Ventilation
  29. Asthma and obstructive sleep apnoea in adults and children – an up-to-date review
  30. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
  31. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review
  32. The association between beta-blocker therapy and daytime sleepiness in obstructive sleep apnoea
  33. Multidimensional indices in the assessment of chronic obstructive pulmonary disease
  34. Asthma-COPD Overlap: A more Simplistic Approach
  35. Chronic obstructive disease and comorbidities (literature review)
  36. Current Approaches to Asthma In 2021
  37. A rare case of intrathymic epidermoid cyst
  38. Asthma and stroke: a narrative review
  39. Adenoid hypertrophy can impact craniofacial growth and lead to obstructive sleep apnea in children
  40. Coenzyme Q10 suplement in chronic obstructive pulmonary disease
  41. Efficiency of different multidimensional indexes for the assessment of the risk of exacerbations in patients with COPD
  42. The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision
  43. Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol
  44. Alpha-1 Antitrypsin Deficiency and Chronic Obstructive Pulmonary Disease: Between Overlaps, Phenotypes and Illnesses
  45. Current Approaches to COPD in 2019
  46. “Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art.”
  47. Spontaneous Pneumomediastinum – a Rare Asthma Complication
  48. Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD
  49. Identification of clinical phenotypes using cluster analyses in COPD patients
  50. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
  51. A MULTILATERAL APPROACH TO COPD COMORBIDITIES
  52. EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD)
  53. COPD and Stroke
  54. Health-related quality of life in different phenotypes of COPD
  55. Assessment of health-related quality of life in different phenotypes of COPD
  56. Bode index in different phenotypes of COPD
  57. To sleep, or not to sleep?
  58. ACOS: current evidence and future research directions
  59. Phenotyping Before Starting Treatment in COPD?
  60. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
  61. Exercise-Induced Pulmonary Edema in Athletes
  62. Editorial: "COPD: More than a Moving Target!"
  63. P51 Clinical effectiveness of procalcitonin based protocols to guide the administration of antibiotics in patients presenting with COPD exacerbations: systematic review and meta-analysis
  64. Prevalence and burden of comorbidities in COPD
  65. Meet Our Assistant Editor
  66. Editorial: Continuous Positive Airway Pressure: Life-Saving Technology
  67. Health-Related Quality of Life in Patients with COPD
  68. Obstructive Sleep Apnea and Hypertension: A Bidirectional Causal Relation
  69. Obstructive Sleep Apnea and Type 2 Diabetes: Dual Interaction
  70. Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea
  71. Editorial from Guest Editor: Current Management of Sleep Apnea and Comorbidities
  72. COPD Phenotypes and Biomarkers: Introducing Personalised Medicine
  73. Management of Stable COPD: An Update
  74. Defining COPD
  75. Imaging for diagnosis and management of tuberculosis